Application and Dosimetric Requirements for Gallium-68-labeled Somatostatin Analogues in Targeted Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors

被引：13

作者：

Taieb, David ^{[1
,2
,3
]}

Garrigue, Philippe ^{[4
]}

Bardies, Manuel ^{[5
]}

Abdullah, Ahmad Esmaeel ^{[1
]}

Pacak, Karel ^{[6
]}

机构：

[1] Aix Marseille Univ, La Timone Univ Hosp, Dept Nucl Med, F-13385 Marseille, France

[2] Aix Marseille Univ, European Ctr Res Med Imaging, Marseille, France

[3] INSERM, Marseille Cancerol Res Ctr, Inst Paoli Calmettes, Marseille, France

[4] Aix Marseille Univ, La Timone Univ Hosp, Dept Radiopharm, Marseille, France

[5] UPS, INSERM, Canc Res Ctr Toulouse, UMR 1037, Toulouse, France

[6] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Natl Inst Hlth, Program Reprod & Adult Endocrinol, Bethesda, MD 20892 USA

来源：

PET CLINICS | 2015年 / 10卷 / 04期

关键词：

PET; Gallium radioisotopes; Somatostatin; Gastroenteropancreatic; Neuroendocrine;

D O I：

10.1016/j.cpet.2015.06.001

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Theranostics of GEP-NETs based on 68Ga-labeled SSTa PET imaging and targeted therapy applying PRRT with 90Y-labeled and/or 177Lu-labeled SSTa has paved the way for personalized medicine ( Fig. 3). Future directions include the clinical use of somatostatin antagonists as targeting peptides for imaging and therapy47 and the development of novel receptor-targeting radiopharmaceuticals that hold promise for theranostics of NETs.

引用

页码：477 / 486

页数：10

共 47 条

[21] DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors [J].

Jiao, Yuchen ;

Shi, Chanjuan ;

Edil, Barish H. ;

de Wilde, Roeland F. ;

Klimstra, David S. ;

Maitra, Anirban ;

Schulick, Richard D. ;

Tang, Laura H. ;

Wolfgang, Christopher L. ;

Choti, Michael A. ;

Velculescu, Victor E. ;

Diaz, Luis A., Jr. ;

Vogelstein, Bert ;

Kinzler, Kenneth W. ;

Hruban, Ralph H. ;

Papadopoulos, Nickolas .

SCIENCE, 2011, 331 (6021) :1199-1203

[22] Molecular imaging with 68Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours [J].

Kaemmerer, Daniel ;

Peter, Luisa ;

Lupp, Amelie ;

Schulz, Stefan ;

Saenger, Joerg ;

Prasad, Vikas ;

Kulkarni, Harshad ;

Haugvik, Sven-Petter ;

Hommann, Merten ;

Baum, Richard Paul .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (09) :1659-1668

[23]

Konijnenberg M, 2007, J NUCL MED, V48, P134

[24] SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors [J].

Kratochwil, C. ;

Stefanova, M. ;

Mavriopoulou, E. ;

Holland-Letz, T. ;

Dimitrakopoulou-Strauss, A. ;

Afshar-Oromieh, A. ;

Mier, W. ;

Haberkorn, U. ;

Giesel, F. L. .

MOLECULAR IMAGING AND BIOLOGY, 2015, 17 (03) :313-318

[25] SOMATOSTATIN RECEPTOR SCINTIGRAPHY WITH [IN-111-DTPA-D-PHE(1)]- AND [I-123-TYR(3)]-OCTREOTIDE - THE ROTTERDAM EXPERIENCE WITH MORE THAN 1000 PATIENTS [J].

KRENNING, EP ;

KWEKKEBOOM, DJ ;

BAKKER, WH ;

BREEMAN, WAP ;

KOOIJ, PPM ;

OEI, HY ;

VANHAGEN, M ;

POSTEMA, PTE ;

DEJONG, M ;

REUBI, JC ;

VISSER, TJ ;

REIJS, AEM ;

HOFLAND, LJ ;

KOPER, JW ;

LAMBERTS, SWJ .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1993, 20 (08) :716-731

[26] Treatment with the radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3] octreotate:: Toxicity, efficacy, and survival [J].

Kwekkeboom, Dik J. ;

de Herder, Wouter W. ;

Kam, Boen L. ;

van Eijck, Casper H. ;

van Essen, Martijn ;

Kooij, Peter P. ;

Feelders, Richard A. ;

van Aken, Maarten O. ;

Krenning, Eric P. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (13) :2124-2130

[27] Molecular pathology and genetics of gastrointestinal neuroendocrine tumours [J].

Lewis, Mark A. ;

Yao, James C. .

CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2014, 21 (01) :22-27

[28] Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors [J].

Marinoni, Ilaria ;

Kurrer, Anja Schmitt ;

Vassella, Erik ;

Dettmer, Matthias ;

Rudolph, Thomas ;

Banz, Vanessa ;

Hunger, Fabio ;

Pasquinelli, Silvan ;

Speel, Ernst-Jan ;

Perren, Aurel .

GASTROENTEROLOGY, 2014, 146 (02) :453-+

[29] PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumors [J].

Ohki, Rieko ;

Saito, Kozue ;

Chen, Yu ;

Kawase, Tatsuya ;

Hiraoka, Nobuyoshi ;

Saigawa, Raira ;

Minegishi, Maiko ;

Aita, Yukie ;

Yanai, Goichi ;

Shimizu, Hiroko ;

Yachida, Shinichi ;

Sakata, Naoaki ;

Doi, Ryuichiro ;

Kosuge, Tomoo ;

Shimada, Kazuaki ;

Tycko, Benjamin ;

Tsukada, Toshihiko ;

Kanai, Yae ;

Sumi, Shoichiro ;

Namiki, Hideo ;

Taya, Yoichi ;

Shibata, Tatsuhiro ;

Nakagama, Hitoshi .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (23) :E2404-E2413

[30] 177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II study [J].

Paganelli, Giovanni ;

Sansovini, Maddalena ;

Ambrosetti, Alice ;

Severi, Stefano ;

Monti, Manuela ;

Scarpi, Emanuela ;

Donati, Caterina ;

Ianniello, Annarita ;

Matteucci, Federica ;

Amadori, Dino .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (10) :1845-1851

← 1 2 3 4 5 →